CNA Financial’s Ascendis Pharma A/S ASND Stock Holding History

CNA Financial’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,985	Closed	-$308K	–	82
2022 Q3	$308K	Sell	2,985 -330	-10%	-$31.3K	0.12%	142
2022 Q2	$308K	Hold	3,315	–	–	0.11%	156
2022 Q1	$389K	Sell	3,315 -251	-7%	-$29.1K	0.12%	161
2021 Q4	$480K	Buy	3,566 +510	+17%	+$75.9K	0.13%	162
2021 Q3	$487K	Sell	3,056 -144	-5%	-$19.7K	0.13%	164
2021 Q2	$421K	Buy	3,200 +410	+15%	+$54.6K	0.12%	176
2021 Q1	$360K	Buy	2,790 +80	+3%	+$12.2K	0.11%	183
2020 Q4	$452K	Buy	2,710 +50	+2%	+$8.27K	0.14%	169
2020 Q3	$410K	Buy	2,660 +210	+9%	+$30.2K	0.15%	148
2020 Q2	$362K	Buy	+2,450	New	+$336K	0.14%	156

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

CNA Financial's ASND Position: Q4 2022 in Review

CNA Financial sold out of Ascendis Pharma A/S (ASND) in Q4 2022, closing a stake of 2,985 shares — an estimated $308K sold.

CNA Financial first reported a position in ASND in Q2 2020 and held it in 10 quarters. The position peaked at $487K in Q3 2021. 187 funds tracked by Wall St. Rank hold ASND as of Q4 2022.

CNA Financial reported no remaining Ascendis Pharma A/S position as of Q4 2022 after selling out during the quarter.
CNA Financial sold 2,985 Ascendis Pharma A/S shares in Q4 2022, an estimated $308K.
CNA Financial first reported a position in Ascendis Pharma A/S in Q2 2020 and held it in 10 quarters.
CNA Financial's Ascendis Pharma A/S position peaked at $487K in Q3 2021.
187 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2022.

Based on CNA Financial's 13F filing for Q4 2022, filed 10 Feb 2023.